Since 2020, updates in the diagnostic criteria for various neuromuscular diseases have emerged by advancements in electrophysiological studies, biomarker research, and imaging modalities. These developments reflect an effort to improve diagnostic accuracy and allow for earlier intervention. This review summarizes the most recent revisions in the diagnostic criteria for amyotrophic lateral sclerosis, primary lateral sclerosis, Guillain-Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy, and myasthenia gravis.

Autonomic dysfunction occurs frequently in multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Patients with either condition may present with autonomic symptoms such as bladder, sexual, cardiovascular, thermoregulatory, and gastrointestinal dysfunction, and fatigue, but autonomic symptoms that affect quality of life are underrecognized in clinical practice. The immunopathogenesis of MS has been considered to be associated with autonomic dysfunction. Applying appropriate treatment strategies for autonomic dysfunction is important to improve the quality of life of patients. Here we review autonomic dysfunction and how this is managed in patients with MS and NMOSD.

Citations

• Sexual function and related predictors in male with multiple sclerosis and neuromyelitis optica spectrum disorder: a case–control study
  Saeed Vaheb, Mohammad Yazdan Panah, Mohammad Mohammadi, Mohammad Amin Sadri, Narges Ebrahimi, Sarina Loghmani, Marjan Beigi, Vahid Shaygannejad, Omid Mirmosayyeb
  The Journal of Sexual Medicine.2025; 22(2): 274.     CrossRef